
北京天衡药物研究院南阳天衡制药厂
北京天衡药物研究院南阳天衡制药厂
北京天衡药物研究院南阳天衡制药厂
北京天衡药物研究院南阳天衡制药厂
Main Products:5,6,7,7α-四氢噻吩并[3,2-c]吡啶-2(4H)-酮对甲苯磺酸盐, (2R,3S,4S,5S)-5-羟基-2,3,4-三(苄氧基)-5-[(苄氧基)甲基]-环己酮, 伏格列波糖,
View moreAbout Us
Contact Supplier
Tovok,BIBW 2992
Health & Medical/Pharmaceuticals & Raw Materials/Chemical APIsNegotiable
Send Inquiry
6,7-Bis(2-methoxyethoxy)quinazolin-4-(3H)-one
Chemicals/Heterocyclic Compounds/Organic IntermediatesNegotiable
Send Inquiry
(2R,3S,4S,5S)-5-Hydroxy-2,3,4-tris(phenylmethoxy)-5-[(phenylmethoxy)methyl]-cyclohexanone
Chemicals/Other Organic Raw Materials/Aromatic CompoundsNegotiable
Send Inquiry
N-Butylsulfonyl-O-(4-(4-pyridinyl)butyl)-L-tyrosine
Chemicals/Pharmaceutical & Biochemical/TyrosineNegotiable
Send Inquiry
4-(4-chlorobutyl)pyridine hydrochloride
Chemicals/Heterocyclic Compounds/PyridineNegotiable
Send Inquiry
2-(Methylsulfonyl)-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole benzenesulfonate
Chemicals/Intermediates/Pesticide IntermediatesNegotiable
Send Inquiry
2-Deoxy-2,2-difluoro-D-erythro pentonic acid gamma-lactone 3,5-dibenzoate
Chemicals/Carboxylic Acid Derivatives/EstersNegotiable
Send Inquiry
Beijing Tianheng Pharmaceutical Research Institute is a high-tech enterprise specializing in the research and development of new drugs, with research areas covering chemical drugs, traditional Chinese medicine, and novel formulations. Over the past nine years of new drug research, it has obtained more than 100 new drug certificates, involving various dosage forms such as active pharmaceutical ingredients, solid preparations, injections, and topical preparations, accumulating substantial experience in the research and development of new drugs.
To meet new market demands, the institute began research on innovative drugs with independent intellectual property rights several years ago. Currently, several projects have made significant progress and are in the final stages of preclinical research.
The institute maintains excellent cooperation with numerous domestic and international manufacturers in areas such as new drug research and development, generic drug contract research, clinical research agency services, and import drug registration agency services.
The institute employs a total of 60 scientific researchers, with an average age of 30. Over two-thirds of the researchers hold master's degrees or higher. Substantial experience, rigorous scientific management, and a high level of professionalism have positioned the institute as a leader in the domestic industry.